{"id":"W3003573046","doi":"10.1016/j.ijcard.2020.01.070","title":"Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries","year":2020,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Janssen Pharmaceuticals; BERLIN-CHEMIE; Daiichi Sankyo Company; Novo Nordisk; Ferring; Daiichi-Sankyo; Merit Medical Systems; Luitpold Pharmaceuticals; Medicines Company; Takeda Pharmaceutical Company; F. Hoffmann-La Roche; Daiichi Sankyo Europe; Abbott Diagnostics; Servier; Bayer; Gilead Sciences; Medtronic; Abiomed; Sanofi; Novartis; Merck; HLS Therapeutics; GlaxoSmithKline; Johnson and Johnson; Thermo Fisher Scientific; Abbott Laboratories; CSL Behring; Bristol-Myers Squibb; Eli Lilly and Company; Biotronik; AstraZeneca; Roche; Siemens; Astellas Pharma US; Salix Pharmaceuticals; Pfizer; Boehringer Ingelheim; Amgen; Regeneron Pharmaceuticals","keywords":"Medicine; Myocardial infarction; Unstable angina; Internal medicine; Kidney disease; Diabetes mellitus; Coronary artery disease; Revascularization; Stroke (engine); Confidence interval; Incidence (geometry); Angina; Risk factor","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001113093,0.0004209422,0.0004964998,0.001287279,0.0003853003,0.00111402,0.0003837614,0.0005081066,0.0005286612],"category_scores_gemma":[0.002281027,0.0002664253,0.000822004,0.002498863,0.0003437067,0.0008529433,0.001014735,0.0006358505,0.0001485566],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003651955,"about_ca_system_score_gemma":0.0005378813,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01172114,"about_ca_topic_score_gemma":0.01193124,"domain_scores_codex":[0.9993796,0.0002000675,0.0001067053,0.0001181934,0.00007318537,0.0001221461],"domain_scores_gemma":[0.9984029,0.0002451604,0.0007814608,0.0001174174,0.0002050761,0.0002479606],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001346552,0.00002405823,0.9977283,0.00002489852,0.000122194,0.0001099236,0.0001216409,0.00009028244,0.0000389942,0.00003432,0.0003496418,0.001221129],"study_design_scores_gemma":[0.00001026255,0.00004300198,0.9991723,0.00001418513,0.00006236444,0.00009902777,0.0003337047,0.00005811042,0.00001270477,0.00001980448,0.0001704138,0.000004128416],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994698,0.0009471169,0.00007874969,0.0001650204,0.00001425276,0.00001230099,0.00327833,0.00000589487,0.0008004346],"genre_scores_gemma":[0.9961185,0.0005326155,0.00005660262,0.00005276498,0.00001149168,0.00001572686,0.003134587,0.000002815753,0.00007480102],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01172114,"threshold_uncertainty_score":0.02330583,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01340034979651625,"score_gpt":0.3102362907541596,"score_spread":0.2968359409576434,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}